Here's What Hedge Funds Think About Sangamo Therapeutics, Inc. (SGMO)
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Sangamo Therapeutics Inc (SGMO)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
Here's What Hedge Funds Think About Sangamo Therapeutics, Inc. (SGMO)
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings.
13G Filing: Adage Capital Management and Sangamo Therapeutics Inc (SGMO)
Adage Capital Partners GP, L.L.C., a limited liability company organized under the laws of the State of Delaware ("ACPGP"), as general partner of ACP with respect to the shares of Common Stock directly...
36 Major Stories Telling What's Happening in the World of Finance Today
"U.S. and European stocks fell on Thursday, along with the U.S. dollar, while U.S.
Is Sangamo Biosciences, Inc. (SGMO) a Good Stock to Invest in?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Here's Why Investors Are Watching Sangamo Biosciences, GNC Holdings, and Three Other Stocks Today
Markets are mixed on Wednesday as investors get ready to digest a flurry of earnings, and await Federal Reserve’s summary of commentary of the current economic condition, also known as the “Beige ...
Earnings Wrap: Transocean (RIG), XPO Logistics (XPO), Exelixis (EXEL), 2 More
All three index futures are pointing north in pre-market trading as the Bank of England just announced that it would cut interest rates for the first time in seven years, to 0.25 basis points.
Can Sangamo Biosciences, Inc. (SGMO) Win the Battle Against its Market Cap Peers?
The 700+ hedge funds and money managers tracked by Insider Monkey have compiled and submitted their 13F filings for the third quarter, which unveiled their equity positions as of September 30.
One Tech Stock Made Investors Happy Today & One Healthcare Company You Should Follow Hedge Funds Into
One of the stocks that stands out on Thursday is Envivio Inc (NASDAQ:ENVI).
Wayne Holman, Ridgeback Capital Like Sangamo Biosciences
Wayne Holman, Ridgeback Capital: Wayne Holman's hedge fund Ridgeback Capital Management recently disclosed the purchasing of some 3.6 million shares of Sangamo Biosciences, Inc.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
